Transparency Market

Research
Meningococcal Vaccines Market - Global Industry
Analysis, Size, Share, Growth, Trends and Forecast,
2013 - 2019

Published Date
28-April-2014

109 Page Report

Buy Now

Request Sample

Press Release
Global Meningococcal Vaccines Market to be Worth US$3.7 billion by
2019: Transparency Market Research
Transparency Market Research
State Tower,
90, State Street, Suite 700.
Albany, NY 12207
United States
www.transparencymarketresearch.com
sales@transparencymarketresearch.com

Meningococcal Vaccines Market

REPORT DESCRIPTION

Meningococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and
Forecast, 2013 - 2019
Transparency Market Research, a U.S. based market intelligence firm has added the report, titled
Meningococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013
- 2019, to its research reports repository. The report states that the global meningococcal vaccines market
has the potential of growing at a CAGR of 14.9% during 2013 and 2019. Growing at this pace, this market
that valued US$1.5 billion in 2012 could achieve a net worth of US$3.7 billion by 2019.
Browse the full report at
http://www.transparencymarketresearch.com/meningococcal-vaccines-market.html
Various strains of meningococcal bacteria cause serious infection to the thin lining surrounding the brain
and spinal cord. The infection results in severe brain damage and can be fatal in 50% cases if left
untreated. The high fatality rate of meningococcal disease is generally considered as a medical emergency.
This is why, federal governments of various countries are actively involved in efforts for spreading
awareness about the severity of the condition. Many government bodies are also involved in the research,
development, and also the distribution of meningococcal vaccines regionally.
Transparency Market Researchs report on the global meningococcal vaccines market presents an allinclusive overview of the market and its various segments.
The report mainly focuses on major market segments based on the types of vaccines available in the
meningococcal vaccine market, such as Polysaccharide Vaccines, Conjugate Vaccines, Combination
Vaccines, and the vaccines in pipeline. The product types are further segmented according to the brands
that feature them. An overview of geographically specific active regional markets is also included in the
report.
Conjugates are expected to lead the global meningococcal vaccines market in the future. By observing
growth at a CAGR of 12.9%, this product segment could amass net worth of nearly US$2.5 billion by 2019.

Transparency Market Research

Meningococcal Vaccines Market

Amongst the various meningococcal vaccines in pipeline currently, Novartiss Bexsero is expected to gain
market shares at the fastest pace, an expected 24.7%, during the forecast period.

We are currently offering a flat 15% discount on all purchases until end of the March 2015!
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1666
The Department of Health, UK, states that Baxsero will be the first vaccine for serogroup B in the
meningococcal vaccines market after its launch in the second quarter of 2014. Pfizers MnB rLP2086 is
another potential future vaccine that is currently in its third phase of trial. The launch of this vaccine, which
has received a Breakthrough Therapy status from the U.S. FDA, is expected to change the complete
outlook of this market by intensifying competition.
Geographically, North America was the leading shareholder of the global meningococcal vaccines market
in 2011 due to government led immunization programs and favorable research and development initiatives
undertaken by major drug companies in this region. Also, every year nearly 1,000 to 2,600 people in the
U.S. contract meningitis from various strains of the bacteria. However, vaccines for only the serotypes A, C,
Y, and W-135 are available in the U.S. market.
Regional market of Asia Pacific is expected to grow at the fastest pace in the global meningococcal
vaccines market, at an estimated CAGR of 17.1%, by the end of 2019. Major drivers of growth in these
regional markets are the low manufacturing cost of vaccines, and transfer of novel manufacturing
technologies from developed countries to these regions.

The global meningococcal vaccines market is segmented as follow:

Meningococcal Vaccines Market, by Type
Polysaccharide Vaccines, by Brand
Menomune
Mencevax
NmVac4
Others

Transparency Market Research

Meningococcal Vaccines Market

Quadri Meningo
Bi Meningo
Conjugate Vaccines, by Brand
Menactra
Menveo
NeisVac-C
Nimenrix
Meningitec
Menjugate
MenAfriVac
Combination Vaccines, by Brand
MenHibrix
Menitorix
Pipeline Vaccines, by Brand
Bexsero
MnB rLP2806
NmVac4-DT
Meningococcal Vaccines Market, by Geography
North America
Europe
Asia-Pacific

Transparency Market Research

Meningococcal Vaccines Market

Rest of the World

Browse More Report on Pharmaceuticals Market:

http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

TABLE OF CONTENT

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Secondary Research
1.3.2 Primary Research
1.4 List of Abbreviations
1.5 Assumptions

Chapter 2 Executive Summary

2.1 Market Snapshot: Global Meningococcal Vaccines Market
2.2 Global Meningococcal Vaccines Market Revenue, 2011 2019 (USD Million)
2.3 Comparative Analysis: Global Meningococcal Vaccines Market, by Geography, 2012 & 2019 (Value %)

Chapter 3 Global Meningococcal Vaccines Market Overview

3.1 Introduction
3.1.1 Meningococcal Disease
3.1.1.1 Clinical Features

Transparency Market Research

Meningococcal Vaccines Market

3.1.1.2 Epidemiology
3.1.1.3 Diagnosis & Treatment
3.1.2 Types of Meningococcal Vaccines
3.2 Regulatory Scenario
3.3 Market Drivers
3.3.1 Developing economies reshaping global health and development
3.3.2 Education and awareness through various non-profit organizations
3.3.3 Travel vaccines for meningococcal disease
3.4 Market Restraints
3.4.1 Disparate age groups and dosage regimen for routine immunization, and unpredictable and
dynamic epidemiology of meningococcal disease
3.4.2 Maintenance of cold chains to deliver vaccines leading to high cost of vaccination
3.5 Market Opportunities
3.5.1 Development of vaccines through collaborations and public private partnerships making vaccines
more affordable
3.5.2 Novel approaches to improve the stability of meningococcal vaccines
3.5.3 Developing halal vaccines
3.6 Porters Five Force Analysis for the Global Meningococcal Vaccines Market
3.6.1 Bargaining Power of Suppliers
3.6.2 Bargaining Power of Buyers
3.6.3 Threat of Substitutes
3.6.4 Threat of New Entrants
3.6.5 Competitive Rivalry
3.7 Market Attractiveness Analysis for the Global Meningococcal Vaccines Market, by Geography

Transparency Market Research

Meningococcal Vaccines Market

Chapter 4 Global Meningococcal Vaccines Market, by Type

4.1 Introduction
4.1.1 Global Meningococcal Vaccines Market Revenue, by Type, 2011 - 2019 (USD Million)
4.2 Comparative Analysis: Global Meningococcal Vaccines Market, by Type, 2012 & 2018 (Value %)
4.3 Polysaccharide Meningococcal Vaccines
4.3.1 Global Polysaccharide Vaccines Market Revenue, by Brand, 2011 - 2019 (USD Million)
4.3.2 Menomune
4.3.2.1 Global Menomune Market Revenue, 2011 - 2019 (USD Million)
4.3.3 Mencevax
4.3.3.1 Global Mencevax Market Revenue, 2011 2014 (USD Million)
4.3.4 NmVac4-A/C/Y/W-135
4.3.4.1 Global NmVac4 Market Revenue, 2011 2015 (USD Million)
4.3.5 Others (Bi Meningo, Quadri Meningo)
4.3.5.1 Global Other Polysaccharide Vaccines Market Revenue, 2011 2019 (USD Million)
4.4 Conjugate Meningococcal Vaccines
4.4.1 Global Conjugate Vaccines Market Revenue, by Brand, 2011 - 2019
4.4.2 Menactra
4.4.2.1 Global Menactra Market Revenue, 2011 - 2019 (USD Million)
4.4.3 Menveo
4.4.3.1 Global Menveo Market Revenue, 2011 - 2019 (USD Million)
4.4.4 NeisVac-C
4.4.4.1 Global NeisVac-C Market Revenue, 2011 - 2019 (USD Million)
4.4.5 Nimenrix
4.4.5.1 Global Nimenrix Market Revenue, 2012 - 2019 (USD Million)

Transparency Market Research

Meningococcal Vaccines Market

4.4.6 Meningitec
4.4.6.1 Global Meningitec Market Revenue, 2011 - 2019 (USD Million)
4.4.7 Menjugate (Meningococcal Group C- CRM197 Conjugate Vaccine)
4.4.7.1 Global Menjugate Market Revenue, 2011 - 2019 (USD Million)
4.4.8 MenAfriVac
4.4.8.1 Global MenAfriVac Market Revenue, 2011 - 2019 (USD Million)
4.5 Combination Meningococcal Vaccines
4.5.1 Global Combination Vaccines Market Revenue, by Brand, 2011 - 2019 (USD Million)
4.5.2 MenHibrix
4.5.2.1 Global MenHibrix Market Revenue, 2013 - 2019 (USD Million)
4.5.3 Menitorix
4.5.3.1 Global Menitorix Market Revenue, 2011 - 2019 (USD Million)
4.6 Pipeline Analysis
4.6.1 Global Meningococcal Vaccines Market Pipeline Forecast, by Brand, 2011 - 2019 (USD Million)
4.6.2 Bexsero
4.6.2.1 Global Bexsero Market Revenue, 2013 - 2019 (USD Million)
4.6.3 MnB rLP2806
4.6.3.1 Global MnB rLP2806 Market Revenue, 2017 - 2019 (USD Million)
4.6.4 NmVac4-A/C/Y/W-135-DT
4.6.4.1 Global NmVac4 DT Market Revenue, 2015 - 2019 (USD Million)

Chapter 5 Global Meningococcal Vaccines Market, by Geography

5.1 Introduction
5.1.1 Global Meningococcal Vaccines Market Revenue, by Geography, 2011 - 2019 (USD Million)

Transparency Market Research

Meningococcal Vaccines Market

5.2 North America

5.2.1 North America Meningococcal Vaccines Market Revenue, 2011 2019 (USD Million)
5.3 Europe
5.3.1 Europe Meningococcal Vaccines Market Revenue, 2011 2019 (USD Million)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Meningococcal Vaccines Market Revenue, 2011 2019 (USD Million)
5.5 Rest of the World
5.5.1 Rest of the World Meningococcal Vaccines Market Revenue, 2011 2019 (USD Million)

Chapter 6 Competitive Landscape

6.1 Market Share by Key Players, 2012 (Value %)
6.1.1 Methodology
6.1.2 Analysis

Chapter 7 Recommendations
7.1 Focus on Low Cost of Manufacturing
7.2 Developing Animal Component Free and Halal Vaccines
7.3 Tapping Emerging Markets
7.4 Collaborating With Community Pharmacies

Chapter 8 Company Profiles

8.1 Baxter International, Inc.
8.1.1 Company Overview
8.1.2 Financial Overview

Transparency Market Research

Meningococcal Vaccines Market

8.1.3 Product Portfolio

8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 Biomed Pvt. Ltd.
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategies
8.2.5 Recent Developments
8.3 GlaxoSmithKline plc
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 JN-International Medical Corporation
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.4.5 Recent Developments
8.5 Novartis International AG
8.5.1 Company Overview
8.5.2 Financial Overview

Transparency Market Research

10

Meningococcal Vaccines Market

8.5.3 Product Portfolio

8.5.4 Business Strategies
8.5.5 Recent Developments
8.6 Nuron Biotech, Inc.
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.5 Recent Developments
8.7 Pfizer, Inc.
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategies
8.7.5 Recent Developments
8.8 Sanofi SA
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.8.5 Recent Developments
8.9 Serum Institute of India Ltd.
8.9.1 Company Overview
8.9.2 Financial Overview

Transparency Market Research

11

Meningococcal Vaccines Market

8.9.3 Product Portfolio

8.9.4 Business Strategies
8.9.5 Recent Developments

Browse Full Press Release @

http://www.transparencymarketresearch.com/pressrelease/meningococcal-vaccinesmarket.htm

About Us
Transparency Market Research is a market intelligence company providing global business information
reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers.

Contact

Transparency Market Research

90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
Browse The Market Research Blog :
https://marketsresearchindustry.wordpress.com/

Transparency Market Research

12